Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer

Richard Bayliss(University of Leeds), Jene Choi(Asan Medical Center)
Research Square
March 29, 2024
Cited by 0


Related Papers